These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 24366000

  • 21. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN.
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [Abstract] [Full Text] [Related]

  • 22. Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.
    Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.
    J Pathol; 2014 Aug; 233(4):392-401. PubMed ID: 24838394
    [Abstract] [Full Text] [Related]

  • 23. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W, Wong N, Wong WL, Lai PB, Zhong S, Johnson PJ.
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [Abstract] [Full Text] [Related]

  • 24. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
    Wong CM, Lee JM, Ching YP, Jin DY, Ng IO.
    Cancer Res; 2003 Nov 15; 63(22):7646-51. PubMed ID: 14633684
    [Abstract] [Full Text] [Related]

  • 25. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
    Zhang CZ, Cao Y, Yun JP, Chen GG, Lai PB.
    Histopathology; 2012 Jun 15; 60(7):1114-24. PubMed ID: 22372401
    [Abstract] [Full Text] [Related]

  • 26. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr 15; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 27. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
    Anwar SL, Albat C, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.
    Int J Cancer; 2013 Aug 01; 133(3):660-70. PubMed ID: 23364900
    [Abstract] [Full Text] [Related]

  • 28. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
    Qin Y, Liu JY, Li B, Sun ZL, Sun ZF.
    World J Gastroenterol; 2004 May 01; 10(9):1276-80. PubMed ID: 15112341
    [Abstract] [Full Text] [Related]

  • 29. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
    Dong ZZ, Yao DF, Wu W, Qiu LW, Yao NH, Yan XD, Yu DD, Chen J.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 01; 20(8):593-7. PubMed ID: 23207153
    [Abstract] [Full Text] [Related]

  • 30. Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma.
    Kinoshita H, Okabe H, Beppu T, Chikamoto A, Hayashi H, Imai K, Mima K, Nakagawa S, Ishimoto T, Miyake K, Yokoyama N, Ishiko T, Baba H.
    Oncol Rep; 2013 Feb 01; 29(2):685-9. PubMed ID: 23229496
    [Abstract] [Full Text] [Related]

  • 31. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 01; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 32. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3494-502. PubMed ID: 18830757
    [Abstract] [Full Text] [Related]

  • 33. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.
    Ann Surg Oncol; 2012 Oct 01; 19(11):3556-65. PubMed ID: 22588469
    [Abstract] [Full Text] [Related]

  • 34. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 35. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y.
    Oncol Rep; 2014 Feb 15; 31(2):693-700. PubMed ID: 24317529
    [Abstract] [Full Text] [Related]

  • 36. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
    Wang B, Tao X, Huang CZ, Liu JF, Ye YB, Huang AM.
    Hepatogastroenterology; 2014 Feb 15; 61(133):1321-6. PubMed ID: 25436304
    [Abstract] [Full Text] [Related]

  • 37. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.
    J Gastroenterol Hepatol; 2012 Jan 15; 27(1):173-80. PubMed ID: 21777276
    [Abstract] [Full Text] [Related]

  • 38. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC, Yeung YS, Wong CM, Chan LK, Poon RT, Ng IO, Yam JW.
    Liver Int; 2010 Jan 15; 30(1):139-48. PubMed ID: 19874489
    [Abstract] [Full Text] [Related]

  • 39. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 15; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 40. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L, Cui Q, Lu Z, Chen J.
    Pancreas; 2012 Mar 15; 41(2):206-11. PubMed ID: 21792082
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.